Chronos Archive seal

Review checklist: Arthur Ashe (HR-ML013)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the choice of TMP-SMX as toxoplasmosis maintenance, the timing of its discontinuation, and the LDL goal.
provenance reviewnot_startedRecent-death rule: only what Ashe made public himself and what was reported publicly, from Encyclopedia Virginia, STAT, PBS NewsHour, and Biography.com. The 1976 heart-attack date in one source is recorded as a dispute.
safe messaging reviewnot_startedHIV claims are marked sensitive; the language is person-first; disclosure is his own decision throughout; death recorded without detail.

Judgment calls (dossier editorial resolutions)

  1. Recent-death rule. Ashe died in 1993. The case uses only what Ashe made public himself, at his April 1992 press conference and in his memoir, as reported in the four sources above, and what was reported publicly at his death. No medical records, family accounts beyond what the sources report, or speculation about undisclosed conditions are used. Claims about HIV are marked sensitive. No sick visit is added, and no illness other than the documented heart disease, toxoplasmosis, and HIV is introduced.
  2. Index age and consistency with what he knew. The index visit on January 12, 2026 maps to January 12, 1989, when he was 45: after his HIV diagnosis in 1988, so the diagnosis was known to him, and long before his public announcement in 1992. The synthetic date of birth is July 10, 1980 (shift 37 years). The chronic-care visits on February 9, April 13, July 13, and October 19, 2026 and the preventive visit on August 17, 2026 (age 46) map to the same days of 1989. The diagnostic admission (September 2025 in the modern frame) maps to September 1988; the sources date the operation only to 1988, and one search listing names September, which was not confirmed in a fetched source. Past medical history and family history include only events before the index date. His announcement and death are in the timeline only.
  3. Heart-attack date. Encyclopedia Virginia dates the heart attack to July 31, 1979, and STAT and Biography.com place the first bypass in 1979; the PBS essay dates a first heart attack to July 1976 at 33. The 1979 date is preferred and the PBS date is linked as a dispute on CLM-0002. The days of the two bypass operations in the modern frame (December 2016 and June 2020, mapping to December 1979 and June 1983) are synthetic; the sources give only the years.
  4. Transfusion in the modern frame. The documented route, a transfusion during the 1983 operation before blood was screened, is kept as history (D). In the modern frame the second operation falls in 2020, when transfusion-transmitted HIV is extremely rare. The episode does not explain this away: the notes say only that he understands he acquired HIV from the transfusion, and the consultation adds one synthetic line that the hospital reported the suspected transfusion-transmitted infection to the blood supplier at diagnosis, which is what a modern hospital would do.
  5. Toxoplasmosis. Sources agree that a left-sided brain mass caused right hand or arm weakness in 1988 and that the diagnosis was toxoplasmosis (PBS calls it fungal; it is a parasite, and the record treats it as one). In the modern frame the lesion is diagnosed by stereotactic biopsy rather than removal, before the HIV result returned. The recovery of the right hand, all counts and viral loads, the regimens, and their dates are synthetic. No source says what treatment he received in 1988, and none is described.
  6. Problems. HIV is coded B20, which applies after any AIDS-defining illness; toxoplasmosis B58.2 (Toxoplasma meningoencephalitis, the ICD-10-CM code for cerebral toxoplasmosis); coronary artery disease I25.10 and old myocardial infarction I25.2, linked to the documented history; hyperlipidemia E78.5 is synthetic. No behavioral-health diagnosis is coded, and the PHQ scores stay below the thresholds, so no structured safety assessment is required.
  7. Person-first language. The record says “person with HIV,” “acquired,” and “HIV infection,” not “victim,” “infected patient,” or “AIDS patient.” Disclosure is always his decision; the consultation and wellness notes keep results and the health care agent in the confidential part of the chart. His spouse and child are mentioned only as supports, and no relative’s health or decision is recorded in any visit note.
  8. Synthetic content. All visits, laboratory values, vital signs, vaccines, medicines, the ECG, the MRI and biopsy, the PHQ and AUDIT-C scores, his never-smoker status, his work routine, and his height (185 cm) are synthetic. The viral load is recorded as 0 when HIV-1 RNA is not detected (below 20 copies/mL), because the schema stores numbers only; the reference range text says so.
  9. Preventive visit. A periodic adult preventive visit (CPT 99396 with 99497 in plain text) was added at age 46. Judgment calls: (1) colorectal cancer screening by colonoscopy is ordered and anal cancer screening deferred to the next visit at his choice, with no results recorded; (2) the syphilis screen is ordered and no result value is recorded; (3) advance care planning names an unnamed health care agent and records only general priorities, including control over his own medical information, and no treatment preference.
  10. Focused visits. The four chronic-care follow-ups (four weeks, three months, six months, and nine months) are documented as focused visits on the DHHS and IAS-USA antiretroviral guidance, the DHHS opportunistic infection guidelines, the HIVMA/IDSA primary care guidance, and the CMID ischemic heart disease and hyperlipidemia monographs. Protocol deviations recorded instead of invented results: (1) the urine albumin test recommended at the start of tenofovir alafenamide were not done in the hospital or at intake (deferred at four weeks), and (2) the ordered urine sample was not collected at three months (deferred again); it was collected at six months and was normal, with no harm evident; (3) the lipid recheck after adding ezetimibe came at 13 weeks, one week outside the 4 to 12 week window, with no effect on care. Trimethoprim-sulfamethoxazole is stopped at nine months, when the CD4 count has been above 200 for more than six months with an undetectable viral load.
  11. Consultation. The infectious diseases referral and the consultation by Priyanka Rao, MD (a fictional consultant), on the day of the four-week visit, are S. The consultant answers the five referral questions in line with what the record shows afterwards: the regimen continues unchanged; abacavir, boosted regimens, and efavirenz are avoided; maintenance therapy stops at nine months by the stated criteria; the three-monthly monitoring, the urine albumin test, the hepatitis B antibody check, the meningococcal, zoster, influenza, and COVID-19 vaccines, and the cancer screening at the preventive visit all follow.
  12. Guideline URLs. clinicalinfo.hiv.gov refuses automated requests (HTTP 403), so its pages could not be fetched. The antiretroviral guideline is cited through its Healthy People 2030 listing, which resolved; the opportunistic infection section URL (node 9358, the Toxoplasma gondii section) was confirmed through search-engine listings of the page and its Spanish version. The IAS-USA and HIVMA/IDSA documents were confirmed through PubMed.
  13. Not used. His memoir Days of Grace and the 1992 press-conference transcript were not fetched and are not quoted. Accounts of his later treatment, his final illness, his father’s death, and his wife’s and daughter’s lives are not used.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-02-09
Progress note 02 (C-CDA)
Urine albumin-to-creatinine ratio on tenofovirAt the start of tenofovir and yearlyNot done when tenofovir alafenamide was started in the hospital or at intake, a deviation from the DHHS and HIVMA guidance. Creatinine is stable, so no harm is evident. Corrective action: urine albumin-to-creatinine ratio ordered with the three-month blood tests
2026-04-13
Progress note 03 (C-CDA)
Urine albumin-to-creatinine ratio on tenofovirAt the start of tenofovir and yearlyOrdered after the deviation recorded at the four-week visit, but the sample was not collected this morning: a second miss. Creatinine is stable, so no harm is evident. Corrective action: the urine sample is now part of the standing order for each blood draw, starting at six months

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-08-17
Progress note 05 (C-CDA)
PreventionColorectal cancer screeningOrderedRecommended from age 45; no prior screening. He chose colonoscopy, and a referral to gastroenterology was placed
2026-08-17
Progress note 05 (C-CDA)
PreventionSyphilis screeningOrderedYearly for sexually active people with HIV; drawn today

Evidence to check

Retrospective claims (R)

None.

Sensitive claims

ClaimGradeStatement
CLM-0004DIn 1988 Ashe had difficulty moving his right hand and arm; a scan showed a mass in the left side of his brain, which surgeons removed, and the diagnosis was toxoplasmosis. Testing then showed that he had HIV and AIDS.
CLM-0005DAshe and his doctors concluded that he had almost certainly acquired HIV from a blood transfusion during his 1983 heart operation, before blood was tested for the virus.
CLM-0006DAshe kept his diagnosis private at first, telling only a few family members and friends. On April 8, 1992, after learning that USA Today planned to report it, he announced at a press conference that he had HIV.
CLM-0008DAshe died in New York City on February 6, 1993, aged 49, of AIDS-related pneumonia. His memoir, Days of Grace, was published after his death.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-01-12HIV-1 viral load42 {copies}/mL (high)High
2026-01-12CD4 count156 /uL (low)Low
2026-01-12Hemoglobin13 g/dL (low)Low
2026-01-12Triglycerides150 mg/dL (high)High
2026-04-13CD4 count218 /uL (low)Low
2026-07-13CD4 count262 /uL (low)Low
2026-10-19CD4 count318 /uL (low)Low